What if a Patient’s Genomics Transformed Treatment for Anxiety & Depression?
“In many cases, especially those that prove hardest to treat, it now can.” Dr. Sharon Hausman-Cohen
Move beyond ‘one-size-fits-all’ treatment with our IntellxxDNA Spotlight on Anxiety and Depression Report.
Intractable Depression or Anxiety Often Has Actionable, Genomic-Based Interventions
Analyze over 40 clinically significant SNPs that influence serotonin, adrenaline, norepinephrine, dopamine, and more.
Understand the genetic components behind situational anxiety, including sugar processing and cortisol levels.
Identify which genetic factors are most important to each patient, allowing for highly personalized interventions.
Clinically-Validated, Trusted
It Goes Beyond Serotonin
Mental health is so much more than just serotonin levels. Finding the root cause of conditions like anxiety and depression requires looking beyond standard bloodwork. Our genomic analysis dives deep into your patients’ unique biochemistry.
Get the Full Picture for Every Patient
To gain a full picture of what’s happening in your patient’s body and mind, we analyze not just neurotransmitters but also inflammatory pathways, micronutrients, and metabolic factors. Our comprehensive analysis includes GABA, dopamine, and glutamate, as well as stress hormones such as cortisol, and regulatory processes like methylation regulators and growth factors.
